España
India
Italia
대한민ęµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민ęµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Plus Therapeutics
PSTV
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.21
-0.01
-0.82%
At close: -
$1.25
0.04
3.31%
After Hours: 7:54 AM EDT
Get Report
Comment
Plus Therapeutics (PSTV) Forecast
News
Earnings
Plus Therapeutics (PSTV) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Plus Therapeutics (NASDAQ:PSTV) Stock
Plus Therapeutics Stock (NASDAQ: PSTV)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 17, 2024
Plus Therapeutics Highlights Presentation, Sa...
Benzinga Newsdesk
Plus Therapeutics Recaps Presentation Of ReSP...
Benzinga Newsdesk
Monday, December 09, 2024
Ascendiant Capital Maintains Buy on Plus Ther...
Benzinga Newsdesk
Tuesday, December 03, 2024
Plus Therapeutics Expands Agreement With Teli...
Benzinga Newsdesk
Tuesday, November 26, 2024
HC Wainwright & Co. Reiterates Buy on Plus Th...
Benzinga Newsdesk
Friday, November 22, 2024
Plus Therapeutics Subsidiary CNSide Diagnosti...
Benzinga Newsdesk
Friday, November 15, 2024
HC Wainwright & Co. Reiterates Buy on Plus Th...
Benzinga Newsdesk
Thursday, November 14, 2024
Plus Therapeutics Q3 EPS $(0.37) Beats $(0.56...
Benzinga Newsdesk
Earnings Scheduled For November 14, 2024
Benzinga Insights
Wednesday, November 13, 2024
A Peek at Plus Therapeutics's Future Earnings
Benzinga Insights
Thursday, November 07, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, November 06, 2024
Plus Therapeutics And SpectronRx Announced Th...
Benzinga Newsdesk
Friday, October 04, 2024
Plus Therapeutics Files For Mixed Shelf Offer...
Benzinga Newsdesk
Tuesday, October 01, 2024
Plus Therapeutics Presented An Update On Ongo...
Benzinga Newsdesk
Monday, September 30, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Dow Tumbles Over 200 Points; Carnival Posts Upbeat Earnings
Avi Kapoor
Friday, September 27, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Tuesday, September 03, 2024
Ascendiant Capital Maintains Buy on Plus Ther...
Benzinga Newsdesk
Friday, August 16, 2024
HC Wainwright & Co. Reiterates Buy on Plus Th...
Benzinga Newsdesk
Wednesday, August 14, 2024
Plus Therapeutics Q2 2024 Adj EPS $(0.71) Mis...
Benzinga Newsdesk
Plus Therapeutics Q2 Sales $1.28M Miss $1.68M...
Benzinga Newsdesk
Tuesday, August 13, 2024
Plus Therapeutics Says CNSide Leptomeningeal ...
Benzinga Newsdesk
Monday, August 12, 2024
Plus Therapeutics Presented Data In Podium Pr...
Benzinga Newsdesk
Friday, June 07, 2024
PLUS THERAPEUTICS Says Greg Fuller Joins Comp...
Benzinga Newsdesk
Wednesday, May 15, 2024
Plus Therapeutics Q1 2024 GAAP EPS $(0.75) Be...
Benzinga Newsdesk
Thursday, May 09, 2024
Plus Therapeutics Has Acquired Assets For The...
Benzinga Newsdesk
Monday, May 06, 2024
Plus Therapeutics shares are trading higher a...
Benzinga Newsdesk
Plus Therapeutics Announced Private Placement...
Benzinga Newsdesk
Monday, April 22, 2024
Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense
Vandana Singh
Plus Therapeutics Says 'Plus now has $23 mill...
Benzinga Newsdesk
Plus Therapeutics Receives $3M Award Recommen...
Benzinga Newsdesk
Monday, March 25, 2024
Plus Therapeutics Announces Validation & Clin...
Benzinga Newsdesk
Monday, March 11, 2024
Plus Therapeutics Has Completed Dosing In Coh...
Benzinga Newsdesk
Tuesday, March 05, 2024
Recap: Plus Therapeutics Q4 Earnings
Benzinga Insights
Plus Therapeutics Q4 EPS $(0.70) Beats $(1.07...
Benzinga Newsdesk
Earnings Scheduled For March 5, 2024
Benzinga Insights
Monday, March 04, 2024
Plus Therapeutics Earnings Preview
Benzinga Insights
Monday, December 18, 2023
Plus Therapeutics Says The Award Payment Of $...
Benzinga Newsdesk
Tuesday, December 12, 2023
Plus Therapeutics Partners With K2bio To Deve...
Benzinga Newsdesk
Monday, November 20, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Thursday, November 09, 2023
Insiders Buying Plus Therapeutics And 2 Other Stocks Under $2
Lisa Levin
Friday, November 03, 2023
Plus Therapeutics Says It Has Been Granted U....
Benzinga Newsdesk
Wednesday, November 01, 2023
Why Plus Therapeutics Stock Popped Today
Ryan Gustafson
Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Tuesday, October 31, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Plus Therapeutics shares are trading higher a...
Benzinga Newsdesk
Plus Therapeutics Announces Share Repurchase ...
Benzinga Newsdesk
Plus Therapeutics Q3 EPS $(1.00) Vs $(2.85) L...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
